Running Head: Influenza Intensity Surveillance.
Tomás Vega, Amparo Larrauri(Instituto de Salud Carlos III), Lisa Domegan(Health Service Executive), Joël Mossong(Luxembourg Institute of Health), Julien, Raúl Ortíz(Universidad de Granada), Pernille Jorgensen(World Health Organization Regional Office for Europe), Jens Nielsen(Statens Serum Institut), José Eugenio Lozano Alonso, René Snacken, T J Meerhoff(Radboud University Nijmegen)
Unknown
January 1, 2015
Cited by 0
Related Papers
Social Contacts and Mixing Patterns Relevant to the Spread of Infectious Diseases
|PLoS Medicine|2008|3.2k
First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020
|Eurosurveillance|2020|715
Estimates of Pandemic Influenza Vaccine Effectiveness in Europe, 2009–2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Multicentre Case-Control Study
|PLoS Medicine|2011|303
Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008
|Eurosurveillance|2008|286